Clinical Trial Update: Exploration of Safety and Efficacy of AzA 15% Foam Twice a Day in Rosacea [Phase 2]

View source ↗

Summary

Phase 2 trial updates safety and efficacy of AzA 15% foam for papulopustular rosacea; results posted in 2013 after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Papulopustular Rosacea

Drugs mentioned

• AzA 15% Foam (azelaic acid 15% foam)

Snippet

Sponsor: LEO Pharma | Conditions: Papulopustular Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2013-07-04